Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8:391–402.
Article PubMed CAS Google Scholar
Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-Implications for human health and treatment perspectives. EMBO Rep. 2020;21:e51034.
Article PubMed PubMed Central CAS Google Scholar
Aguado JM, Silva JT, Fernandez-Ruiz M, Cordero E, Fortun J, Gudiol C, et al. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev (Orlando). 2018;32:36–57.
Article PubMed CAS Google Scholar
Anesi JA, Lautenbach E, Thom KA, Tamma PD, Blumberg EA, Alby K, et al. Clinical outcomes and risk factors for carbapenem-resistant Enterobacterales bloodstream infection in solid organ transplant recipients. Transplantation. 2023;107:254–63.
Giannella M, Freire M, Rinaldi M, Abdala E, Rubin A, Mularoni A, et al. Development of a risk prediction model for carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a multinational cohort study. Clin Infect Dis. 2021;73:e955–66.
Chen Y, Wang WL, Zhang W, Zhang YT, Tang SX, Wu PP, et al. Risk factors and outcomes of carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a retrospective study in a Chinese population. Infect Drug Resist. 2020;13:4039–45.
Article PubMed PubMed Central CAS Google Scholar
Giannella M, Bartoletti M, Campoli C, Rinaldi M, Coladonato S, Pascale R, et al. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clin Microbiol Infect. 2019;25:1525–31.
Article PubMed CAS Google Scholar
Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2009;58:256–60.
Taylor SA, Venkat V, Arnon R, Gopalareddy VV, Rosenthal P, Erinjeri J, et al. Improved outcomes for liver transplantation in patients with biliary atresia since pediatric end-stage liver disease implementation: analysis of the society of pediatric liver transplantation registry. J Pediatr. 2020;219:89–97.
Ronan V, Yeasin R, Claud EC. Childhood development and the microbiome-the intestinal microbiota in maintenance of health and development of disease during childhood development. Gastroenterology. 2021;160:495–506.
Fu P, Xu H, Jing C, Deng J, Wang H, Hua C, et al. Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020. Microbiol Spectr. 2021;9:e0028321.
Tanimura S, Chuah SL, Shimizu S, Sakamoto S, Kasahara M, Nakagawa S. Pattern of infection after pediatric liver transplant and its associated risk factors. Pediatr Transplant. 2025;29:e70032.
Pouch SM, Patel G, AST Infectious Diseases Community of Practice. Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13594.
Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol. 2021;59:e0021321.
Huang J, Wang H, Fan ST, Zhao B, Zhang Z, Hao L, et al. The national program for deceased organ donation in China. Transplantation. 2013;96:5–9.
Yuan X, Xu Q, Du F, Gao X, Guo J, Zhang J, et al. Development and validation of a model to predict cognitive impairment in traumatic brain injury patients: a prospective observational study. EClinicalMedicine. 2025;80:103023.
Article PubMed PubMed Central Google Scholar
Singh SK, Poddar U, Mishra R, Srivastava A, Yachha SK. Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy. Hepatol Int. 2020;14:138–44.
Article PubMed CAS Google Scholar
Zhang W, Chen Y, Zhang Y, Wang R, Wang W, Bai X, et al. Carbapenems versus cephalosporin or piperacillin-tazobactam as perioperative antibiotic prophylaxis in liver transplant recipients with model for end-stage liver disease scores of ≥30: a retrospective study in a Chinese population. Infect Drug Resist. 2022;15:4487–94.
Article PubMed PubMed Central Google Scholar
Men TY, Wang JN, Li H, Gu Y, Xing TH, Peng ZH, et al. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum beta-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. Transpl Infect Dis. 2013;15:14–21.
Article PubMed CAS Google Scholar
Liu J, Zhang H, Feng D, Wang J, Wang M, Shen B, et al. Development of a risk prediction model of subsequent bloodstream infection after carbapenem-resistant Enterobacteriaceae isolated from perianal swabs in hematological patients. Infect Drug Resist. 2023;16:1297–312.
Article PubMed PubMed Central CAS Google Scholar
Sun Y, Yu L, Gao W, Cai J, Jiang W, Lu W, et al. Investigation and analysis of the colonization and prevalence of carbapenem-resistant Enterobacteriaceae in pediatric liver transplant recipients. Infect Drug Resist. 2021;14:1957–66.
Article PubMed PubMed Central Google Scholar
Yang TT, Luo XP, Yang Q, Chen HC, Luo Y, Zhao YM, et al. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better? Antimicrob Resist Infect Control. 2020;9:49.
Article PubMed PubMed Central Google Scholar
Feier FH, Chapchap P, Pugliese R, Da Fonseca EA, Carnevale FC, Moreira AM, et al. Diagnosis and management of biliary complications in pediatric living donor liver transplant recipients. Liver Transpl. 2014;20:882–92.
Guirguis RN, Nashaat EH, Yassin AE, Ibrahim WA, Saleh SA, Bahaa M, et al. Biliary complications in recipients of living donor liver transplantation: a single-centre study. World J Hepatol. 2021;13:2081–103.
Article PubMed PubMed Central Google Scholar
Pereira MR, Scully BF, Pouch SM, Uhlemann AC, Goudie S, Emond JE, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015;21:1511–9.
Article PubMed PubMed Central Google Scholar
Op Den Dries S, Sutton ME, Lisman T, Porte RJ. Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation. 2011;92:373–9.
Neto JS, Costa CM, De Assis AM, Pugliese R, Benavides MR, Carnevale FC, et al. Treatment strategies for bile leak following pediatric liver transplantation. Pediatr Transplant. 2024;28:e14814.
Article PubMed CAS Google Scholar
Danziger-Isakov L, Steinbach WJ, Paulsen G, Munoz FM, Sweet LR, Green M, et al. A multicenter consortium to define the epidemiology and outcomes of pediatric solid organ transplant recipients with inpatient respiratory virus infection. J Pediatr Infect Dis Soc. 2019;8:197–204.
Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505–12.
Article PubMed PubMed Central CAS Google Scholar
Lombardi A, Alagna L, Palomba E, Viero G, Tonizzo A, Mangioni D, et al. New antibiotics against multidrug-resistant Gram-negative bacteria in liver transplantation: clinical perspectives, toxicity, and PK/PD properties. Transpl Int. 2024;37:11692.
Comments (0)